Indeed, ST6GAL1 expression is decreased at advanced stage of CRC, with a significantly higher expression at stages I and II (non-metastatic) and lower expression at stages III and IV (metastatic) compared with normal tissues [70]. Here, ST6GAL1 is linked to colorectal carcinoma.